Shimada Shinya, Kuramoto Masafumi, Marutsuka Takashi, Yagi Yasushi, Baba Hideo
Department of Surgery, Yatsushiro Social Insurance General Hospital, Japan.
Rev Recent Clin Trials. 2011 Sep;6(3):266-70. doi: 10.2174/157488711796575603.
EIPL (extensive intra-operative peritoneal lavage) therapy was developed as a prophylactic strategy for peritoneal recurrence, with the goal of improving the quality of life and survival span for advanced gastric cancer patients with peritoneal free cancer cells. The purpose of this article is to review the therapy's contribution to a remarkable improvement in the 5-year survival for patients with positive lavage cytology on prospective randomized controlled clinical trials. We also advocate for the adoption of the EIPL as the optimal treatment protocol for advanced gastric cancer.
术中广泛腹腔灌洗（EIPL）疗法是作为一种预防腹膜复发的策略而开发的，目的是提高伴有腹腔游离癌细胞的晚期胃癌患者的生活质量和生存期。本文旨在回顾该疗法在前瞻性随机对照临床试验中对灌洗细胞学阳性患者5年生存率显著提高所做出的贡献。我们还主张采用EIPL作为晚期胃癌的最佳治疗方案。
